SEC Form D · filed January 3, 2023
Reprise Biomedical, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Ronald Eibensteiner · PLYMOUTH, MNDirectorPhillip Nalbone · PLYMOUTH, MNDirectorErwin Kelen · PLYMOUTH, MNDirectorCarrie Powers · PLYMOUTH, MNExec · DirectorHoward Root · PLYMOUTH, MNExec · DirectorPhil Nalbone · PLYMOUTH, MNDirectorPaul H. Sartori · Charlottesville, VAExec · DirectorDaniel Auerbach · South San Francisco, CADirectorPeter Morrow · San Diego, CADirectorPaul Kim · Wilmington, DEDirectorAlex Thompson · Provo, UTExec · DirectorChristopher P. Hill · San Antonio, TXDirectorThomas Pace · Austin, TXExec · DirectorAnne Marie Morley · CHICAGO, ILExec · DirectorStephen Swanson · CHICAGO, ILDirectorZia Rahman · Alpharetta, GADirectorSri Srinivasari · Chicago, ILDirectorWilliam L. Butler, Jr · Cincinnati, OHDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗